High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success
Author:
Funder
Canadian Association of Radiation Oncologists
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference33 articles.
1. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol,2014
2. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy;Yamada;Brachytherapy,2012
3. High dose rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer;Zwahlen;Brachytherapy,2010
4. Comparison of biologically equivalent dose–volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy;Pieters;Radiother Oncol,2008
5. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT;Deutsch;Brachytherapy,2010
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer;Radiotherapy and Oncology;2023-09
2. Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II trial;Brachytherapy;2023-01
3. A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer;Radiotherapy and Oncology;2022-06
4. Prostate cancer brachytherapy: SFRO guidelines 2021;Cancer/Radiothérapie;2022-02
5. PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study;Brachytherapy;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3